FANCJ suppresses microsatellite instability and lymphomagenesis independent of the fanconi anemia pathway

Genes and Development

Volumn 29, Issue 24, 2015, Pages 2532-2546

  Matsuzaki, Kenichiro ^a   Borel, Valerie ^a   Adelman, Carrie A ^a   Schindler, Detlev ^b   Boulton, Simon J ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

DNA repair; FANCJ; Fanconi anemia; Genome stability; Microsatellite instability

Indexed keywords

DNA; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP J PROTEIN; HELICASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CAMPTOTHECIN; FANCJ PROTEIN, MOUSE; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA PROTEIN; MITOMYCIN;

AGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DAMAGE; DNA STRUCTURE; FANCONI ANEMIA; GERM CELL; LYMPHOMA; LYMPHOMAGENESIS; MATING; MICROSATELLITE INSTABILITY; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; U2OS CELL LINE; ANIMAL; CELL CULTURE; CELL LINE; DEFICIENCY; DRUG EFFECTS; FEMALE; FIBROBLAST; GENETIC PREDISPOSITION; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CAMPTOTHECIN; CELL LINE; CELLS, CULTURED; DNA DAMAGE; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; FIBROBLASTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA; MALE; MICE, KNOCKOUT; MICROSATELLITE INSTABILITY; MITOMYCIN; NEOPLASMS, GLANDULAR AND EPITHELIAL; ULTRAVIOLET RAYS;

EID: 84949995795     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.272740.115     Document Type: Article

References (49)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, et al. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–816.
2. Adelman CA, Lolo RL, Birkbak NJ, Murina O, Matsuzaki K, Horejsi Z, Parmar K, Borel V, Skehel JM, Stamp G, et al. 2013. HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis. Nature 502: 381–384.
3. Alter BP. 2003. Cancer in Fanconi anemia, 1927–2001. Cancer 97: 425–440.
4. Alter BP, Kupfer G. 2002. Fanconi anemia. In GeneReviews (Internet) (ed. Pagon RA, et al.), University of Washington, Seattle, Seattle, WA. http://www.ncbi.nlm.nih.gov/books/NBK1401.
5. Bakker ST, van de Vrugt HJ, Visser JA, Delzenne-Goette E, van der Wal A, Berns MA, van de Ven M, Oostra AB, de Vries S, Kramer P, et al. 2012. Fancf-deficient mice are prone to develop ovarian tumours. J Pathol 226: 28–39.
6. Barber LJ, Youds JL, Ward JD, McIlwraith MJ, O’Neil NJ, Petalcorin MI, Martin JS, Collis SJ, Cantor SB, Auclair M, et al. 2008. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135: 261–271.
7. Boland CR, Goel A. 2010. Microsatellite instability in colorectal cancer. Gastroenterology 138: 2073–2087.e3.
8. Boyer AS, Grgurevic S, Cazaux C, Hoffmann JS. 2013. The human specialized DNA polymerases and non-B DNA: vital relationships to preserve genome integrity. J Mol Biol 425: 4767–4781.
9. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K. 2005. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37: 953–957.
10. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, et al. 1994. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258–261.
11. BroshRMJr, Cantor SB. 2014. Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia. Front Genet 5: 372.
12. Cannavo E, Gerrits B, Marra G, Schlapbach R, Jiricny J. 2007. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J Bioll Chem 282: 2976–2986.
13. Castillo Bosch P, Segura-Bayona S, Koole W, van Heteren JT, Dewar JM, Tijsterman M, Knipscheer P. 2014. FANCJ promotes DNA synthesis through G-quadruplex structures. EMBO J 33: 2521–2533.
14. Cheung I, Schertzer M, Rose A, Lansdorp PM. 2002. Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA. Nat Genet 31: 405–409.
15. Clauson C, Scharer OD, Niedernhofer L. 2013. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair. Cold Spring Harb Perspect Med 3: a012732.
16. Crossan GP, Patel KJ. 2012. The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J Pathol 226: 326–337.
17. Deans AJ, West SC. 2011. DNA interstrand crosslink repair and cancer. Nat Rev Cancer 11: 467–480.
18. Devon RS, Porteous DJ, Brookes AJ. 1995. Splinkerettes—improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res 23: 1644–1645.
19. Gari K, Leon Ortiz AM, Borel V, Flynn H, Skehel JM, Boulton SJ. 2012. MMS19 links cytoplasmic iron–sulfur cluster assembly to DNA metabolism. Science 337: 243–245.
20. Gupta R, Sharma S, Sommers JA, Jin Z, Cantor SB, Brosh RM Jr. 2005. Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J Biol Chem 280: 25450–25460.
21. Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS, Grompe M. 2003. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev 17: 2021–2035.
22. Kim H, D’Andrea AD. 2012. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev 26: 1393–1408.
23. Levitus M, Rooimans MA, Steltenpool J, Cool NF, Oostra AB, Mathew CG, Hoatlin ME, Waisfisz Q, Arwert F, de Winter JP, et al. 2004. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 103: 2498–2503.
24. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, et al. 2005. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37: 934–935.
25. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, et al. 2005. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37: 931–933.
26. Li GM. 2008. Mechanisms and functions of DNA mismatch repair. Cell Res 18: 85–98.
27. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. 1993. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5: 279–282.
28. Litman R, Peng M, Jin Z, Zhang F, Zhang J, Powell S, Andreassen PR, Cantor SB. 2005. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8: 255–265.
29. London TB, Barber LJ, Mosedale G, Kelly GP, Balasubramanian S, Hickson ID, Boulton SJ, Hiom K. 2008. FANCJ is a structurespecific DNA helicase associated with the maintenance of genomic G/C tracts. J Biol Chem 283: 36132–36139.
30. Mirkin SM. 2007. Expandable DNA repeats and human disease. Nature 447: 932–940.
31. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, et al. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science 263: 1625–1629.
32. Parmar K, D’Andrea A, Niedernhofer LJ. 2009. Mouse models of Fanconi anemia. Mutat Res 668: 133–140.
33. Peng M, Litman R, Xie J, Sharma S, Brosh RM, Cantor SB. 2007. The FANCJ/MutLα interaction is required for correction of the cross-link response in FA-J cells. EMBO J 26: 3238–3249.
34. Peng M, Xie J, Ucher A, Stavnezer J, Cantor SB. 2014. Crosstalk between BRCA–Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses. EMBO J 33: 1698–1712.
35. Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, Jonasdottir A, Besenbacher S, Lundin P, Stacey SN, Gudmundsson J, et al. 2011. Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet 43: 1104–1107.
36. Rudolf J, Makrantoni V, Ingledew WJ, Stark MJ, White MF. 2006. The DNA repair helicases XPD and FancJ have essential iron– sulfur domains. Mol Cell 23: 801–808.
37. Sarkies P, Murat P, Phillips LG, Patel KJ, Balasubramanian S, Sale JE. 2012. FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA. Nucleic Acids Res 40: 1485–1498.
38. Schwab RA, Nieminuszczy J, Shin-ya K, Niedzwiedz W. 2013. FANCJ couples replication past natural fork barriers with maintenance of chromatin structure. J Cell Biol 201: 33–48.
39. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, et al. 2006. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet 38: 1239–1241.
40. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T. 2009. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138: 90–103.
41. Sommers JA, Rawtani N, Gupta R, Bugreev DV, Mazin AV, Cantor SB, Brosh RM Jr. 2009. FANCJ uses its motor ATPase to destabilize protein–DNA complexes, unwind triplexes, and inhibit RAD51 strand exchange. J Biol Chem 284: 7505–7517.
42. Uringa EJ, Lisaingo K, Pickett HA, Brind’Amour J, Rohde JH, Zelensky A, Essers J, Lansdorp PM. 2012. RTEL1 contributes to DNA replication and repair and telomere maintenance. MolrBiol Cell 23: 2782–2792.
43. Vannier JB, Pavicic-Kaltenbrunner V, Petalcorin MI, Ding H, Boulton SJ. 2012. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149: 795–806.
44. Wang G, Vasquez KM. 2014. Impact of alternative DNA structures on DNA damage, DNA repair, and genetic instability. DNA Repair (Amst) 19: 143–151.
45. Wu Y, Shin-ya K, Brosh RM Jr. 2008. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol 28: 4116–4128.
46. Xie J, Guillemette S, Peng M, Gilbert C, Buermeyer A, Cantor SB. 2010a. An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy. Cancer Prev Res 3: 1409–1416.
47. Xie J, Litman R, Wang S, Peng M, Guillemette S, Rooney T, Cantor SB. 2010b. Targeting the FANCJ–BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass. Oncogene 29: 2499–2508.
48. Youds JL, Barber LJ, Ward JD, Collis SJ, O’Neil NJ, Boulton SJ, Rose AM. 2008. DOG-1 is the Caenorhabditis elegans BRIP1/FANCJ homologue and functions in interstrand cross-link repair. Mol Cell Biol 28: 1470–1479.
49. Zhao J, Bacolla A, Wang G, Vasquez KM. 2010. Non-BDNAstructure- induced genetic instability and evolution. Cell Mol Life Sci 67: 43–62.